HORIZON-HLTH-2022-TOOL-11
HORIZON-HLTH-2022-TOOL-11
- Programme
- HORIZON
- Funded projects (dataset)
- 15
- EU contribution (sum)
- €123,301,932
- Portal deadline
- —
Leading topic in historical projects: HORIZON-HLTH-2022-TOOL-11-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN2 coordinated
- MEDICAL UNIVERSITY OF GRAZ2 coordinated
- BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1 coordinated
- CHRU1 coordinated
- CEA1 coordinated
- EUROPEAN BIOMEDICAL RESEARCH INSTITUTE OD SALERNO1 coordinated
- HUS1 coordinated
- INSERM1 coordinated
- IRCCS AOU BO1 coordinated
- MEDIZINISCHE UNIVERSITAET WIEN1 coordinated
- STICHTING AMSTERDAM UMC1 coordinated
- UMC UTRECHT1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- REGIONH4 topic projects
- Leiden University Medical Center3 topic projects
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3 topic projects
- INCLIVA3 topic projects
- RADBOUDUMC3 topic projects
- UOXF3 topic projects
- UoB3 topic projects
- UNIBO2 topic projects
- ECRIN2 topic projects
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 3 shared
- 2 shared
- 2 shared
- 2 shared
- IRCCS AOU BO · REGIONH2 shared
IT ↔ DK
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- IRCCS AOU BO · UNIBO2 shared
IT ↔ IT
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH · RESEARCH AND INNOVATION SERVICES DOO ZA USLUGE2 shared
DE ↔ HR
- 2 shared
- 2 shared
- UNIPD · RADBOUDUMC2 shared
IT ↔ NL
- INCLIVA · IRCCS AOU BO2 shared
ES ↔ IT
- 2 shared
- 2 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 15
- Median orgs / project
- 15
- Min / max orgs
- 8 – 25
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Netherlands40
- Italy23
- United Kingdom21
- France21
- Germany20
- Belgium16
- Denmark14
- Spain14
- Sweden8
- Switzerland6
- Greece5
- Poland4
- Austria4
- Finland4
- Portugal4
- United States3
- Romania2
- Ireland2
Organization types
- university75 orgs · 95 rows
- research_institute30 orgs · 39 rows
- sme37 orgs · 39 rows
- other19 orgs · 19 rows
- company16 orgs · 17 rows
- public_body10 orgs · 16 rows
Topics in funded projects
- HORIZON-HLTH-2022-TOOL-11-01HORIZON-HLTH-2022-TOOL-11-01· 9 projects
- HORIZON-HLTH-2022-TOOL-11-02HORIZON-HLTH-2022-TOOL-11-02· 6 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| PoCCardio Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio) | HORIZON | €13,978,057 |
| OPADE Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tool | HORIZON | €9,997,594 |
| MORPHEUS PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY | HORIZON | €9,958,833 |
| BIOTOOL-CHF BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure | HORIZON | €9,600,663 |
| METHYLOMIC DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. | HORIZON | €9,376,995 |
| PRIME-CKD Personalized Drug Response: IMplementation and Evaluation in CKD | HORIZON | €9,242,241 |
| SQUEEZE Maximising Impact of Prescription Drugs in Rheumatoid Arthritis | HORIZON | €9,197,603 |
| HT-ADVANCE Improving treatment efficacy in hypertension by biomarker-guided personalised decision support | HORIZON | €8,649,616 |
| Hypermarker Personalised pharmacometabolomic optimisation of treatment for hypertension | HORIZON | €8,046,250 |
| Real4Reg Development, optimisation and implementation of artificial intelligence methods for real world data analyses in regulatory decision-making and health technology assessment along the product lifecycle | HORIZON | €6,999,425 |
| More-EUROPA More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making | HORIZON | €6,997,523 |
| ONCOVALUE Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time | HORIZON | €6,953,004 |
| REALM Real-world-data Enabled Assessment for heaLth regulatory decision-Making | HORIZON | €6,659,650 |
| REDDIE Real-world evidence for decisions in diabetes | HORIZON | €4,788,834 |
| INSAFEDARE INNOVATIVE APPLICATIONS OF ASSESSMENT AND ASSURANCE OF DATA AND SYNTHETIC DATA FOR REGULATORY DECISION SUPPORT | HORIZON | €2,855,645 |